Login / Signup

Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas.

Shingo KomuraKenji ItoSho OhtaTomoyo UkaiMio KabataFumiaki ItakuraKatsunori SemiYutaka MatsudaKyoichi HashimotoHirofumi ShibataMasamitsu SoneNorihide JoKazuya SekiguchiTakatoshi OhnoHaruhiko AkiyamaKatsuji ShimizuKnut WoltjenManabu OzawaJunya ToguchidaTakuya YamamotoYasuhiro Yamada
Published in: Nature communications (2019)
Clear cell sarcoma (CCS) is a rare soft tissue sarcoma caused by the EWS/ATF1 fusion gene. Here, we established induced pluripotent stem cells (iPSCs) from EWS/ATF1-controllable murine CCS cells harboring sarcoma-associated genetic abnormalities. Sarcoma-iPSC mice develop secondary sarcomas immediately after EWS/ATF1 induction, but only in soft tissue. EWS/ATF1 expression induces oncogene-induced senescence in most cell types in sarcoma-iPSC mice but prevents it in sarcoma cells. We identify Tppp3-expressing cells in peripheral nerves as a cell-of-origin for these sarcomas. We show cell type-specific recruitment of EWS/ATF1 to enhancer regions in CCS cells. Finally, epigenetic silencing at these enhancers induces senescence and inhibits CCS cell growth through altered EWS/ATF1 binding. Together, we propose that distinct responses to premature senescence are the basis for the cell type-specificity of cancer development.
Keyphrases